Thus, these data and the results of the experiment on the loss and gain of function of NEAT1/miR-101 in T24 and 5637 cells suggested that we have constructed a novel model of regulation in which abnormal NEAT1 expression modulated BC cell development apparently via the miR-101/VEGF-C pathway. This evidence concerns the gene NEAT1 and breast cancer.